Effects of Fish Oil, Lipid Mediators, Derived from Docosahexaenoic Acid, and Their Co-Treatment against Lipid Metabolism Dysfunction and Inflammation in HFD Mice and HepG2 Cells
Nutrients · 2023
DOI: 10.3390/nu15020427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Yan Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeongeup-si 56212, Republic of Korea. Hauptthemen laut MEDLINE: Fish Oils, Lipid Metabolism. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT.
Abstract (Originalsprache)
Although fish oil (FO) and lipid mediators (LM) derived from polyunsaturated fatty acids can prevent obesity, their combined effects and cellular metabolism remain unclear. Therefore, this study aimed to examine the potential protective and metabolic effects of FO in combination with LM (a mixture of 17S-monohydroxy docosahexaenoic acid, resolvin D5, and protectin DX [3:47:50], derived from docosahexaenoic acid (DHA)) on palmitic acid (PA)-induced HepG2 cells and high-fat- diet (HFD)-induced C57BL/6J mice after 9-week treatment. Lipid metabolism disorders and inflammation induced by HFD and PA were substantially reduced after FO and LM treatment. Further, FO and LM treatments reduced lipid accumulation by increasing fatty acid oxidation via peroxisome proliferator-activated receptor α and carnitine-palmitoyl transferase 1 as well as by decreasing fatty acid synthesis via sterol regulatory element-binding protein-1c and fatty acid synthase. Finally, FO and LM treatment reduced inflammation by blocking the NF-κB signaling pathway. Importantly, the combination of FO and LM exhibited more robust efficacy against nonalcoholic fatty liver disease, suggesting that FO supplemented with LM is a beneficial dietary strategy for treating this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeongeup-si 56212, Republic of Korea.
- Department of Bioactive Material Sciences, The Institute for Molecular Biology and Genetics, Jeonbuk National University, Jeonju 54896, Republic of Korea.
- Faculty of Biotechnology, College of Applied Life Sciences, Jeju National University, Jeonju 63243, Republic of Korea.
- Cell Factory Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon-si 34141, Republic of Korea.
- Healthcare Technology Institute, Kolon Advanced Research Center, 110 Magokdong-ro, Seoul 07793, Republic of Korea.
ORCID-Profile: Heonsik Choi, Yong-Suk Jang
Förderung
- Ministry of Science and ICT
Zitieren
APA
Su, Y., Choi, H. S., Choi, J. H., Kim, H. S., Lee, G. Y., Cho, H. W., Choi, H., Jang, Y. S., & Seo, J. W. (2023). Effects of Fish Oil, Lipid Mediators, Derived from Docosahexaenoic Acid, and Their Co-Treatment against Lipid Metabolism Dysfunction and Inflammation in HFD Mice and HepG2 Cells. Nutrients. https://doi.org/10.3390/nu15020427
Vancouver
Su Y, Choi HS, Choi JH, Kim HS, Lee GY, Cho HW, et al. Effects of Fish Oil, Lipid Mediators, Derived from Docosahexaenoic Acid, and Their Co-Treatment against Lipid Metabolism Dysfunction and Inflammation in HFD Mice and HepG2 Cells. Nutrients. 2023. doi:10.3390/nu15020427
BibTeX
@article{Su2023,
author = {Su, Yan and Choi, Hack-Sun and Choi, Jong-Hyun and Kim, Hee-Sik and Lee, Gil-Yong and Cho, Hee-Won and Choi, Heonsik and Jang, Yong-Suk and Seo, Jeong-Woo},
title = {Effects of Fish Oil, Lipid Mediators, Derived from Docosahexaenoic Acid, and Their Co-Treatment against Lipid Metabolism Dysfunction and Inflammation in HFD Mice and HepG2 Cells},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15020427}
}
EUVIMED